Newborn Screening for Pompe Disease

Chien, Yin-Hsiu [HerausgeberIn] ; Wang, Raymond [HerausgeberIn]

Englisch

Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute [2021], 2021

1 Online-Ressource (146 p.)

English

978-3-0365-0580-0

978-3-0365-0581-7

Handle: 20.500.12854/76581

*Technology: general issues

Book Industry Communication: TB

Pompe disease, also known as acid maltase deficiency or acid alpha-glucosidase deficiency, in its most severe form results in a rapidly progressive, neonatal-onset skeletal and cardiomyopathy, leading to early infantile death without treatment. The development of treatment with recombinant enzyme replacement therapy radically transformed the clinical trajectory of those affected, enabling long-term ventilator-free survival with resolution of cardiomyopathy. These positive clinical outcomes resulted in the implementation of newborn screening programs for Pompe disease across the world. This Special Issue highlights some of the experiences of Pompe screening programs worldwide and discusses public policy and ethical issues elicited by presymptomatic screening for Pompe disease

 

https://directory.doabooks.org/handle/20.500.12854/76581 Kostenfrei zugänglich ohne Registrierung

Elektronische Ressource - frei verfügbar

BIBTEX - ENDNOTE - RIS